About Cooper Companies Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.coopercos.com/
Frequently Asked Questions
What is the 52-week range for COO?
The 52-week high is $89.83 and the 52-week low is $51.01.
What is the P/E ratio for COO?
The Price to Earnings (P/E) ratio is 18.98.
What is the dividend yield for COO?
The indicated annual dividend yield is 0.02%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 6.88%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 13.46%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.69.
Analyst Recommendation Trends
Wall Street analyst consensus for COO over the last few months:
Latest COO News
Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?
Insider doubled down after stock fell 16% over the past year, signaling confidence in the contact lens and surgical care provider's recovery prospects.
New CooperVision® Consumer Insights Report Reveals Multifocal Contact Lenses Are Viewed as a Leading Anti-Aging Solution
New research from CooperVision reveals that vision remains an overlooked, yet high potential part of the healthy aging conversation as consumers increasingly invest in products and services that help them look and feel younger. The Unmet Opportunities: Multifocal Contact Lenses and the Anti-Aging Movement (U.S.) report highlights evolving attitudes towards aging and receptiveness to multifocal contact lenses, revealing largely untapped opportunities for eye care professionals (ECPs) to introduce
Seneca Polytechnic and CooperVision Canada open Contact Lens Centre of Excellence to help advance the future of vision care
New facility expands hands-on learning opportunities and strengthens connections between education, industry and patient care CooperVision Contact Lens Centre of Excellence The new CooperVision Contact Lens Centre of Excellence at Newnham Campus provides students with experiences that reflect today’s evolving eye care environment. TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- As the demand for vision care continues to grow, preparing the next generation of eye care professionals has never been mor
Is Jana Partners Right that Cooper (COO) Needs a Different Kind of Leadership?
Activist campaigns tend to surface when a stock’s performance no longer matches its story, and The Cooper Companies, Inc. (NASDAQ:COO) is a case in point. In mid-September 2026, Jana Partners, which built its stake in the contact lens maker roughly a year ago. It began pushing Cooper to replace CEO Albert White and its board […]
Is Cooper Companies (COO) Undervalued After Opening Its New Vision Centre?
Cooper Companies (COO) just opened The Vision Centre in Southampton, a global hub that brings together research, clinical work, pilot manufacturing, and advanced technology to help move new contact lens products toward market more quickly. The backdrop for this new hub is a share price that has retreated sharply over 2026. Cooper Companies has a 30 day share price return of down 23.8% and a year to date share price return of down 31.7%, while the 1 year total shareholder return is down 18%...
COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
The Cooper Companies opens a global innovation hub in England and unveils six contact lens programs to support sustainable long-term growth.
CooperCompanies (COO) Keeps CooperSurgical and Expands Buybacks. What Did the Strategic Review Reveal?
With marginal growth across key metrics during the third quarter, The Cooper Companies Inc. (NASDAQ:COO) also finalized its strategic review process, which was initially announced in December last year. In Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision, we highlighted the company’s 1% year-over-year topline growth during the recently reported quarter, which […]
CooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre Opening
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye CareSAN RAMON, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today reinforced its commitment to accelerate growth at CooperVision with the opening of its new global innovation hub, The Vision Centre, and the announcement of six major product advancements that have been accelerated to launch over the next several years: The build-out of the world's first & only complete family of 1-d
CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements
CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced six major product advancements that have been accelerated to launch over the next several years. The announcements were made as CooperVision brings together research and development, clinical expertise, pilot manufacturing, advanced technologies, and commercial capabilities to accelerate the development and commercialization of breakthrough solutions
Activist investor urges Cooper Companies to replace CEO, sell some assets
Citing “chronic underperformance,” Jana Partners is calling for new leadership and for the company to evaluate the sale of its fertility and medical device assets.
3 Out-of-Favor Stocks with Open Questions
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
A Failed Auction and a 15% Drop: Is Cooper Companies (COO) a Value Trap or a Bargain?
For almost nine months, The Cooper Companies, Inc. (NASDAQ:COO) has been trying to sell its CooperSurgical unit. But on September 9, 2026, the company ended the strategic review it had launched in December 2025 and decided to keep the business. The reason is that the bids received were not in shareholders’ interest and reflected a […]
Costco, BlackBerry To Headline Earnings In A Muted Week
Preview next weekâs market movers: Fed, yields, PMI, jobless claims, durable goods, earnings (Costco, BB), dividends & IPOs. Read here for more.
Top S&P500 movers in Friday's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.
Discover which S&P500 stocks are making waves on Friday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
How Is Cooper Companies' Stock Performance Compared to Other Medical Instruments & Supplies Stocks?
As Cooper Companies has lagged behind its industry peers over the past year, Wall Street analysts maintain a cautious outlook on its prospects.
1 Value Stock with Impressive Fundamentals and 2 We Turn Down
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
‘Crisis of Its Own Creation’: Activist JANA Blasts Cooper, Demands CEO Search
Activist firm Jana Partners calls for leadership overhaul and asset sales at Cooper Companies (COO) amid governance concerns.
Activist Calls for Cooper Cos. to Seek New CEO. What It Means for the Barron’s Stock Pick.
Cooper Cos. stock rises as activist investor Jana Partners calls for the company to search for a new CEO and sell a key business segment.
The Bull Case For Cooper Companies (COO) Could Change Following CooperSurgical Retention And Capital Plan Shift
In September 2026, The Cooper Companies completed a broad strategic review, ultimately deciding to retain CooperSurgical after assessing potential sale offers, while also outlining revised capital allocation plans and operational initiatives for CooperVision and CooperSurgical. The Board cited temporary factors such as a new competitor in non-hormonal IUDs and the impact of recent fertility litigation settlements as reasons for a perceived valuation gap that made selling CooperSurgical less...
JANA Partners Calls For Cooper Companies Board To Commence Immediate External CEO Search, Appoint New Board Chair And Evaluate Asset Sales
JANA Partners ("JANA") today announced that it has sent a letter to the Board of Directors (the "Board") of The Cooper Companies, Inc. (NASDAQ:COO) ("Cooper" or the "Company")
The Wall Street Journal Reported Jana Partners Wants Contact-Lens Maker Cooper Cos. To Replace The CEO, Citing Letter
https://www.wsj.com/business/deals/jana-partners-pushes-contact-lens-maker-cooper-to-replace-its-ceo-4a6f74ad?eafs_enabled=false
Which S&P500 stocks are moving on Thursday?
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Thursday's session: gap up and gap down stock in the S&P500 index
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Wondering what's happening in today's S&P500 pre-market session?
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Cooper Companies: A Little More Compelling At This Price
Cooper Companies (COO) upgraded to Hold after a 31% drop.
Needham Reiterates Buy on Cooper Companies, Maintains $73 Price Target
Needham analyst David Saxon reiterates Cooper Companies (NASDAQ:COO) with a Buy and maintains $73 price target.
Cooper Stock Dropped and Put Volume Soared Before Bad News. What Happened?
The medical devices maker took a 5% hit on its stock before two big pieces of news—a guidance cut and the decision not to sell its women’s health business.
3 of Wall Street’s Favorite Stocks We Approach with Caution
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
The Cooper Companies (COO) Faces Near-Term Pressure from Slowing Contact Lens Demand
The Cooper Companies, Inc. (NASDAQ:COO) cut its fiscal 2026 profit and revenue forecasts after weaker-than-expected demand for contact lenses weighed on its CooperVision business. The company now expects adjusted earnings of $4.51–$4.55 per share, down from its previous forecast of $4.58–$4.66, while revenue guidance was reduced to $4.23–$4.25 billion from $4.29–$4.32 billion. Third-quarter revenue came in […]
International Markets and The Cooper Companies (COO): A Deep Dive for Investors
Examine The Cooper Companies' (COO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision
The Cooper Companies Inc. (NASDAQ:COO), a leading medical device company, announced its third quarter fiscal 2026 results on September 9. Topline went up 1% to $1.066 billion in comparison with the same quarter last year, which also included 1% organic growth. The company posted quarterly adjusted diluted EPS of $1.15, which represented a 4% jump […]
Mizuho Maintains Outperform on Cooper Companies, Lowers Price Target to $75
Mizuho analyst Anthony Petrone maintains Cooper Companies (NASDAQ:COO) with a Outperform and lowers the price target from $85 to $75.
Deal Dispatch: Bending Spoons Acquires Miro For $1.35B, Kinetik Up For Sale, LIV Golf Bankruptcy
Read this week's top deal updates, including Bending Spoons' Miro deal, Chime's Stride Bank purchase, and the LIV Golf bankruptcy.
Dow Tumbles Over 300 Points Amid Surge in Oil Prices: Fear & Greed Index Remains in ‘Fear’ Zone
U.S. stocks fell as oil topped $100 and inflation fears grew; CNN Fear & Greed dropped to 33, remaining in the Fear zone.
COO Q2 Deep Dive: Inventory Actions and Strategic Review Shape Guidance
Medical device company CooperCompanies (NASDAQ:COO) missed Wall Street’s revenue expectations in Q2 CY2026, with sales flat year on year at $1.07 billion. The company’s full-year revenue guidance of $4.24 billion at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $1.15 per share was 2.7% above analysts’ consensus estimates.
Why CooperCompanies (COO) Stock Is Trading Lower Today
Shares of medical device company CooperCompanies (NASDAQ:COO) fell 13.9% in the afternoon session after the company reported weak second-quarter results impacted by channel inventory destocking and decided to retain its CooperSurgical business.
Thursday's session: top gainers and losers in the S&P500 index
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
Why is CooperCompanies Stock Down 15% Today?
Cooper won't sell its Surgical arm, and it was forced to cut forward guidance. Wall Street didn't like that.
Barron’s Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap
Cooper Cos. stock has fallen about 25% since Barron’s recommended it, but a low valuation, aggressive share buybacks, and takeover potential bolster the bull case.
What's going on in today's session: S&P500 movers
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Cooper (COO) Q3 2026 Earnings Call Transcript
Record free cash flow and a $307M tax benefit offset near-term revenue headwinds.
William Blair Downgrades Cooper Companies to Market Perform
William Blair analyst Steven Lichtman downgrades Cooper Companies (NASDAQ:COO) from Outperform to Market Perform.
The Surprising Pockmarks On Cooper's Earnings That Caused Its Stock To Dive
Investors hammered Cooper Companies on Thursday after the medtech's fiscal third-quarter sales lagged Wall Street's expectations.
Cooper Companies Failed to Sell CooperSurgical at Attractive Valuation, BofA Says
Cooper Companies (COO) could not sell CooperSurgical at an attractive valuation given competition fr
2 Medical-Device Stocks Lighting Up the Options Pits
Both AXGN and COO are seeing unusual options volume
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down
Cooper Companies' Q3 EPS beats estimates as expense controls offset softer revenues, while U.S. inventory cuts pressure CooperVision and weigh on shares.
Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High
Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.
Wall Street Lunch: Yields Hit Financial Crisis Highs As Inflation Raises Fed Hike Odds
Our top story so far, treasury yields are on the march higher, hitting levels not seen since the Financial Crisis.
Apple, TSMC, SpaceX, Cooper Cos., Macy’s, and More Stocks That Explain Today’s Market
Stocks fell on Thursday after wholesale inflation rose in line with expectations, increasing odds that the Federal Reserve will hike rates at its meeting next week. Taiwan Semiconductor Manufacturing Co. dropped 2.4% even as the Taiwanese chip manufacturer reported record monthly revenue for August.
Wells Fargo Maintains Equal-Weight on Cooper Companies, Lowers Price Target to $61
Wells Fargo analyst Larry Biegelsen maintains Cooper Companies (NASDAQ:COO) with a Equal-Weight and lowers the price target from $66 to $61.
Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls
Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls
Stifel Maintains Buy on Cooper Companies, Lowers Price Target to $70
Stifel analyst Jonathan Block maintains Cooper Companies (NASDAQ:COO) with a Buy and lowers the price target from $85 to $70.
Stocks making the biggest moves midday: Oracle, AeroVironment, American Eagle, Micron, Macy's & more
Here are some of the companies making headlines in midday trading.
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 76.4% to $4.3 during Thursday's regular session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma (AMEX:AEON) shares
Why Cooper Stock Plunges After Earnings
Cooper Companies Stock falls after a revenue miss, weaker Q4 guidance and channel inventory pressure trigger analyst target cuts.
Citigroup Maintains Neutral on Cooper Companies, Lowers Price Target to $60
Citigroup analyst Joanne Wuensch maintains Cooper Companies (NASDAQ:COO) with a Neutral and lowers the price target from $80 to $60.
Which S&P500 stocks are moving before the opening bell on Thursday?
Discover the top S&P500 movers in Thursday's pre-market session and stay informed about market dynamics.
Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results
U.S. stocks fell Thursday as the Dow dropped 300+ points; Macy’s slid on weak guidance, while oil rose and producer prices accelerated.
The Cooper Companies, Inc. Q3 2026 Earnings Call Summary
Moby summary of The Cooper Companies, Inc.'s Q3 2026 earnings call
These stocks that are showing activity before the opening bell on Thursday.
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Here Are Thursday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Amgen, AngloGold Ashanti, Caterpillar, Chewy, Meta Platforms, Novartis, NVIDIA, SK hynix, and More
Markets are taking a beating as crude oil surges past $100 and Treasury yields hit multi-year highs, setting up a make-or-break inflation report that could seal the Fed's next move. Wall Street analysts are already repositioning across semiconductors, biotech, and energy ahead of the fallout.
Piper Sandler Downgrades Cooper Companies to Neutral, Lowers Price Target to $59
Piper Sandler analyst Jason Bednar downgrades Cooper Companies (NASDAQ:COO) from Overweight to Neutral and lowers the price target from $86 to $59.
Cooper Stock Heads For 52-Week Low After Q3 Miss, Multiple Downgrades – Analyst Sees 'Limited Near-Term Appeal'
According to TheFly, Baird flagged the company’s increasingly challenging margin leverage heading into fiscal 2027, saying it limits COO stock's near-term appeal
JP Morgan Maintains Neutral on Cooper Companies, Lowers Price Target to $58
JP Morgan analyst Robbie Marcus maintains Cooper Companies (NASDAQ:COO) with a Neutral and lowers the price target from $71 to $58.
2 Reasons Cooper Companies Stock Is By Far the Worst in the S&P 500 Today
Contact lens maker Cooper Companies just sprung a surprise that no one saw coming. The market had been looking ahead to the potential sale of its women’s health and fertility business CooperSurgical. The stock tumbled more than 15% ahead of the open Thursday, by far the biggest faller in the in premarket trading.
TSMC, Cooper Cos., American Eagle, Oracle, and More Stocks That Explain Today’s Market
FEATURE Stock futures were edging higher on Thursday, even as oil carried on rising having topped $100 a barrel for the first time since July the previous session. Taiwan Semiconductor Manufacturing Co.
UBS Maintains Neutral on Cooper Companies, Lowers Price Target to $66
UBS analyst Patrick Wood maintains Cooper Companies (NASDAQ:COO) with a Neutral and lowers the price target from $75 to $66.
Update: Cooper Shares Fall Pre-Bell After Fiscal Q3 Sales Miss Weighs on Adjusted Earnings Beat, Cut in Full-Year Guidance
(Updates with the stock move in the headline and the first paragraph.) Cooper Companies (COO) sha
The Cooper Companies Inc (COO) (Q3 2026) Earnings Call Highlights: Record Cash Flow and a $307 ...
The Cooper Companies Inc (COO) beat earnings for the 11th straight quarter with record free cash flow of $273 million, but proactive U.S. channel destocking and a looming tax hike cloud fiscal 2027.
Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday
Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed unchanged.
Stock Market Today: Dow Futures Rise, S&P 500 Falls as Trump Promises $5,000 Dividend After Midterm Elections— AVAV, AEO, COO, ORCL in Focus (UPDATED)
U.S. stock futures were mixed on Thursday, as the Dow Jones and S&P 500 indices advanced, while the Nasdaq 100 index fell.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 48.8% to $3.63 during Thursday's pre-market session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma (AMEX:AEON) stock
Limoneira Posts Downbeat Q3 Results, Joins Cooper Companies, Navan And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. futures rose, while Limoneira fell 8.4% after missing earnings and sales estimates. Resolution Minerals and Cooper led other premarket decliners.
These Analysts Slash Their Forecasts On Cooper Companies Following Q3 Results
CooperCompanies beat Q3 EPS but missed sales and cut FY26 guidance; shares fell 16.8% as analysts lowered targets and downgraded the stock.
Stocks making the biggest moves premarket: Macy's, Meta, Apple, Novartis and more
These are the stocks posting the largest moves in the premarket.
This Chewy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts downgraded Chewy, Cooper Companies, AngloGold Ashanti and Crescent Capital BDC, cutting ratings and/or price targets.
Market-Moving News for September 10th
AEO: -14% | Shares of American Eagle Outfitters are trading lower after the company reported Q2 financial results. The company disclosed that tariff refunds boosted its profit. COO: -16% | Cooper shares are trading
B of A Securities Downgrades Cooper Companies to Neutral, Lowers Price Target to $65
B of A Securities analyst Craig Bijou downgrades Cooper Companies (NASDAQ:COO) from Buy to Neutral and lowers the price target from $80 to $65.
Baird Downgrades Cooper Companies to Neutral, Lowers Price Target to $61
Baird analyst Jeff Johnson downgrades Cooper Companies (NASDAQ:COO) from Outperform to Neutral and lowers the price target from $85 to $61.
Needham Maintains Buy on Cooper Companies, Lowers Price Target to $73
Needham analyst David Saxon maintains Cooper Companies (NASDAQ:COO) with a Buy and lowers the price target from $86 to $73.
Why AeroVironment Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
AeroVironment surged 5.8% premarket after beating Q1 revenue and EPS estimates; Synergy CHC led gainers, while Ribbon Acquisition fell.
Macy's, Oracle and 3 Stocks to Watch Heading Into Thursday
Macy's, Adobe and Oracle report earnings; Cooper cuts guidance after mixed results, while American Eagle cites a tariff refund and shares fall.
The Cooper Companies (COO) Stock Plunges Nearly 16% After Hours: Here's Why
Cooper Companies stock drops after hours on Q3 earnings, strategic review, and guidance update.
A Look Back at Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including CooperCompanies (NASDAQ:COO) and its peers.
Cooper Companies Q3 Earnings Call Highlights
Cooper Companies (NASDAQ:COO) reported third-quarter fiscal 2026 revenue of $1.066 billion, up about 1% on both a reported and organic basis, as record free cash flow and earnings growth offset pressure at its CooperVision contact lens business from planned U.S. channel inventory reductions. Non-GA
The Cooper Companies, Inc. (COO) Q3 2026 Earnings Call Transcript
The Cooper Companies, Inc. (COO) Q3 2026 Earnings Call September 9, 2026 5:00 PM EDTCompany ParticipantsKim Duncan - Vice President of Investor Relations...
The Cooper Companies (COO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for The Cooper Companies (COO) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The Cooper Companies (COO) Beats Q3 Earnings Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of +3.60% and -2.97%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
CooperCompanies (NASDAQ:COO) Falls After Revenue Miss and Soft Q4 Guidance Offset Larger Buyback
Cooper (COO) shares slid ~15% as Q3 revenue missed and Q4 guidance trailed estimates, pressured by CooperVision weakness; buyback was raised to $3B.
Cooper Companies tumbles on weak guidance, strategic review conclusion
Investing.com -- CooperCompanies (NASDAQ:COO) shares plunged 15% in after-hours trading Wednesday after the medical device company reported third-quarter results that missed revenue expectations and issued fourth-quarter and full-year guidance significantly below analyst estimates.
Stay updated with the stocks that are on the move in today's after-hours session.
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Cooper Companies Fiscal Q3 Adjusted Earnings, Revenue Rise; Q4 Guidance Set
Cooper Companies (COO) reported fiscal Q3 adjusted earnings late Wednesday of $1.15 per diluted shar
CooperCompanies (NASDAQ:COO) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 16.8%
Medical device company CooperCompanies (NASDAQ:COO) fell short of the market’s revenue expectations in Q2 CY2026, with sales flat year on year at $1.07 billion. The company’s full-year revenue guidance of $4.24 billion at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $1.15 per share was 2.7% above analysts’ consensus estimates.
CooperCompanies Announces Third Quarter 2026 Results
SAN RAMON, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2026. Revenue increased 1% year-over-year to $1.066 billion, including 1% organic growth.GAAP diluted earnings per share (EPS) of $2.24, compared with $0.49 in last year's third quarter, primarily driven by a $307.2 million discrete tax benefit resulting from the favorable completion of a U.K. t
CooperCompanies Completes Strategic Review, Increases Share Repurchase Authorization
Board Unanimously Concludes to Retain CooperSurgical Expands Share Repurchase Authorization from $2 billion to $3 billion Board Remains Open to All Value Options that Create Shareholder Value SAN RAMON, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- CooperCompanies today announced the completion of its strategic review process first announced in December 2025. The comprehensive process focused on identifying opportunities to enhance long-term shareholder value including a review of the Company's por
Full Transcript: Cooper Companies Q3 2026 Earnings Call
Cooper Companies (NASDAQ:COO) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below. This transcript is brought to you by
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers EXoZymes (NASDAQ:EXOZ) stock increased by 7.5% to $7.18 during Wednesday's after-market session. The market value of their outstanding shares is at $58.5 million. AEON Biopharma (AMEX:AEON) shares rose
Stocks making the biggest moves after hours: AeroVironment, American Eagle, Cooper Companies & more
Here are some of the names making headlines in extended trading.
Cooper Companies Sees Q4 Adj EPS $1.05-$1.09 vs $1.19 Est; Sees Sales $1.057B-$1.080B vs $1.106B Est
Cooper Companies (NASDAQ:COO) is looking for Q4 Adj EPS of $1.05-$1.09 vs $1.19 analyst estimate. sees sales of $1.057 billion-$1.080 billion vs $1.106 billion analyst estimate.
Cooper Companies Lowers FY2026 Adj EPS Guidance from $4.58-$4.66 to $4.51-$4.55 vs $4.63 Est; Lowers FY2026 Sales Guidance from $4.285B-$4.321B to $4.229B-$4.252B vs $4.307B Est
Cooper Companies (NASDAQ:COO) lowers FY2026 Adj EPS guidance from $4.58-$4.66 to $4.51-$4.55 vs $4.63 analyst estimate. Lowers FY2026 sales outlook from $4.285 billion-$4.321 billion to $4.229 billion-$4.252 billion vs
Cooper Companies Q3 Adj. EPS $1.15 Beats $1.12 Estimate, Sales $1.066B Miss $1.098B Estimate
Cooper Companies (NASDAQ:COO) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.12 by 2.68 percent. This is a 4.55 percent increase over earnings of $1.10 per share from the
CooperCompanies Completes Strategic Review; Plans To Retain CooperSurgical; Expands Stock Buyback Plan From $2B To $3B
CooperCompanies today announced the completion of its strategic review process first announced in December 2025. The comprehensive process focused on identifying opportunities to enhance long-term shareholder value
The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store?
COO Q3 earnings are likely to benefit from CooperVision strength, improving fertility trends and efficiency gains offsetting Asia-Pacific pressure.
Cooper Companies Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Cooper Companies will report Q3 earnings Sept. 9; analysts expect EPS of $1.12 and revenue of $1.10B.
Stock Market: Will S&P 500 Open Up or Down Today?
Will the S&P 500 open higher? Polymarket odds rise to 66% as Wall Street weighs $99 Brent crude, Apple's product event, and upcoming CPI data.
CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect.
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC
PHG's AI-powered 3D Auto CFQ shows stronger agreement with cardiac MRI than 2D PISA, supporting its cardiovascular ultrasound strategy.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-16 | Kurzius Lawrence Erik | +10,000 | $54.932 | $549,320 |
| 2026-09-14 | Rosebrough Walter M Jr | +3,000 | $54.29 | $162,870 |
| 2026-09-14 | Kurzius Lawrence Erik | +10,000 | $53.915 | $539,150 |
| 2026-09-11 | Keel Paul A | +4,701 | $53.18 | $249,999 |
| 2026-09-11 | Rosebrough Walter M Jr | +7,000 | $54.11 | $378,770 |
| 2026-07-01 | Keel Paul A | +2,814 | - | - |
| 2026-04-01 | Rosebrough Walter M Jr | -832 | - | - |
| 2026-04-01 | Rosebrough Walter M Jr | +832 | - | - |
| 2026-04-01 | Carbone Barbara | +3,779 | - | - |
| 2026-04-01 | Carbone Barbara | -3,050 | - | - |
| 2026-04-01 | Carbone Barbara | +3,050 | - | - |
| 2026-04-01 | Rivas Maria | +3,779 | - | - |
| 2026-04-01 | Rivas Maria | -3,322 | - | - |
| 2026-04-01 | Rivas Maria | +3,322 | - | - |
| 2026-04-01 | Jay Colleen | +4,157 | - | - |
| 2026-04-01 | Jay Colleen | -3,322 | - | - |
| 2026-04-01 | Jay Colleen | +3,322 | - | - |
| 2026-04-01 | Rosebrough Walter M Jr | +3,779 | - | - |
| 2026-04-01 | Kurzius Lawrence Erik | +3,779 | - | - |
| 2026-04-01 | Kurzius Lawrence Erik | -3,322 | - | - |
| 2026-04-01 | Kurzius Lawrence Erik | +3,322 | - | - |
| 2026-04-01 | Lucchese Cynthia L | +3,779 | - | - |
| 2026-04-01 | Lucchese Cynthia L | -3,322 | - | - |
| 2026-04-01 | Lucchese Cynthia L | +3,322 | - | - |
| 2026-04-01 | WEISS ROBERT S | +3,779 | - | - |
| 2026-04-01 | WEISS ROBERT S | -3,654 | - | - |
| 2026-04-01 | WEISS ROBERT S | +3,654 | - | - |
| 2026-04-01 | MADDEN TERESA S | +3,779 | - | - |
| 2026-04-01 | MADDEN TERESA S | -3,322 | - | - |
| 2026-04-01 | MADDEN TERESA S | +3,322 | - | - |
| 2026-01-12 | Jay Colleen | -7,064 | - | - |
| 2026-01-12 | Jay Colleen | +7,064 | $39.4 | $278,322 |
| 2026-01-08 | Warner Gerard H III | -3,154 | - | - |
| 2026-01-08 | Warner Gerard H III | -2,940 | - | - |
| 2026-01-08 | Warner Gerard H III | -2,652 | - | - |
| 2026-01-08 | Warner Gerard H III | -1,540 | - | - |
| 2026-01-08 | Warner Gerard H III | -1,232 | - | - |
| 2026-01-08 | Warner Gerard H III | -1,354 | $83.13 | $112,558 |
| 2026-01-08 | Warner Gerard H III | -1,501 | $83.13 | $124,778 |
| 2026-01-08 | Warner Gerard H III | -787 | $83.13 | $65,423 |
| 2026-01-08 | Warner Gerard H III | -629 | $83.13 | $52,289 |
| 2026-01-08 | Warner Gerard H III | -1,714 | $83.13 | $142,485 |
| 2026-01-08 | Warner Gerard H III | +1,540 | - | - |
| 2026-01-08 | Warner Gerard H III | +2,940 | - | - |
| 2026-01-08 | Warner Gerard H III | +1,232 | - | - |
| 2026-01-08 | Warner Gerard H III | +3,154 | - | - |
| 2026-01-08 | Warner Gerard H III | +2,652 | - | - |
| 2026-01-08 | Sheffield Holly R | -3,154 | - | - |
| 2026-01-08 | Sheffield Holly R | -3,304 | - | - |
| 2026-01-08 | Sheffield Holly R | -1,592 | - | - |
| 2026-01-08 | Sheffield Holly R | -1,641 | $83.13 | $136,416 |
| 2026-01-08 | Sheffield Holly R | -738 | $83.13 | $61,350 |
| 2026-01-08 | Sheffield Holly R | -1,462 | $83.13 | $121,536 |
| 2026-01-08 | Sheffield Holly R | +3,304 | - | - |
| 2026-01-08 | Sheffield Holly R | +1,592 | - | - |
| 2026-01-08 | Sheffield Holly R | +3,154 | - | - |
| 2026-01-08 | Andrews Brian G | -3,528 | - | - |
| 2026-01-08 | Andrews Brian G | -1,893 | $83.13 | $157,365 |
| 2026-01-08 | Andrews Brian G | +3,528 | - | - |
| 2026-01-08 | McBride Daniel G | -4,163 | - | - |
| 2026-01-08 | McBride Daniel G | -4,556 | - | - |
| 2026-01-08 | McBride Daniel G | -4,168 | - | - |
| 2026-01-08 | McBride Daniel G | -2,119 | $83.13 | $176,152 |
| 2026-01-08 | McBride Daniel G | -2,121 | $83.13 | $176,319 |
| 2026-01-08 | McBride Daniel G | -2,415 | $83.13 | $200,759 |
| 2026-01-08 | McBride Daniel G | +4,163 | - | - |
| 2026-01-08 | McBride Daniel G | +4,556 | - | - |
| 2026-01-08 | McBride Daniel G | +4,168 | - | - |
| 2026-01-08 | White Albert G III | -18,340 | - | - |
| 2026-01-08 | White Albert G III | -9,419 | $83.13 | $783,001 |
| 2026-01-08 | White Albert G III | +18,340 | - | - |
| 2026-01-03 | Rosebrough Walter M Jr | +832 | - | - |
| 2025-12-22 | Lucchese Cynthia L | +1,784 | $84.06 | $149,963 |
| 2025-12-18 | Rivas Maria | +1,000 | $82.13 | $82,130 |
| 2025-12-17 | Kurzius Lawrence Erik | +2,000 | $82.5 | $165,000 |
| 2025-12-16 | Sheffield Holly R | +1,230 | $80.75 | $99,323 |
| 2025-12-16 | White Albert G III | +10,000 | $80.8 | $808,000 |
| 2025-12-12 | WEISS ROBERT S | -7,500 | - | - |
| 2025-12-09 | Warner Gerard H III | +15,921 | - | - |
| 2025-12-09 | Warner Gerard H III | +7,960 | - | - |
| 2025-12-09 | Sheffield Holly R | +15,921 | - | - |
| 2025-12-09 | Sheffield Holly R | +7,960 | - | - |
| 2025-12-09 | Andrews Brian G | +19,105 | - | - |
| 2025-12-09 | Andrews Brian G | +9,552 | - | - |
| 2025-12-09 | McBride Daniel G | +21,016 | - | - |
| 2025-12-09 | McBride Daniel G | +10,508 | - | - |
| 2025-12-09 | White Albert G III | +84,613 | - | - |
| 2025-12-09 | White Albert G III | +42,306 | - | - |